Bartholdson John A.
SEC Form 4 history across 1 companies, 7 transactions and 4 filings.
Available history · May 22, 2026 – Sep 21, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
OFIXOrthofix Medical Inc. | Bartholdson John A.10% | P · buyAmended filingSEC filing ↗ | $1.68MView disclosure → | |
OFIXOrthofix Medical Inc. | Bartholdson John A.10% | P · buyAmended filingSEC filing ↗ | $1.04MView disclosure → | |
OFIXOrthofix Medical Inc. | Bartholdson John A.10% | S · saleSEC filing ↗ | $1.68MView disclosure → | |
OFIXOrthofix Medical Inc. | Bartholdson John A.10% | S · saleSEC filing ↗ | $1.04MView disclosure → | |
OFIXOrthofix Medical Inc. | Bartholdson John A.10% | S · saleSEC filing ↗ | $200kView disclosure → | |
OFIXOrthofix Medical Inc. | Bartholdson John A.10% | S · saleSEC filing ↗ | $202kView disclosure → | |
OFIXOrthofix Medical Inc. | Bartholdson John A.10% | S · saleSEC filing ↗ | $2.58MView disclosure → |
Latest Form 4 facts
Quick context from source filings
buy at Orthofix Medical Inc. on Sep 21, 2026 valued at $1,683,381.
Review SEC filingMonthly open-market activity
Last 3 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| May 2026 | 0 | 1 | $0.00 | $2,589,206.40 | -$2,589,206.40 |
| Aug 2026 | 0 | 2 | $0.00 | $402,744.10 | -$402,744.10 |
| Sep 2026 | 2 | 2 | $2,732,097.00 | $2,732,097.00 | $0.00 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
5 observations · May 22, 2026 – Sep 21, 2026. Window ends at the latest available report, not today.
View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| May 22, 2026 | 3,461,216 | May 29, 2026 | View transaction |
| Sep 18, 2026 | 3,581,216 | Sep 22, 2026 | View transaction |
| Sep 18, 2026 | 3,581,216 | Sep 23, 2026 | Amended transaction |
| Sep 21, 2026 | 3,771,216 | Sep 22, 2026 | View transaction |
| Sep 21, 2026 | 3,771,216 | Sep 23, 2026 | Amended transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Bartholdson John A. Insider Activity FAQ
SEC Form 4 context
Who is Bartholdson John A.?
Bartholdson John A. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001382909.
Which companies has Bartholdson John A. reported transactions for?
Orthofix Medical Inc., LINCOLN EDUCATIONAL SERVICES CORP
When was Bartholdson John A.'s latest insider buy?
buy at Orthofix Medical Inc. on Sep 21, 2026 valued at $1,683,381.
When was Bartholdson John A.'s latest insider sale?
sale at Orthofix Medical Inc. on Sep 21, 2026 valued at $1,683,381.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.